Glycine for Sleep: What It Does, the Right Dose, and How It Compares to Melatonin
September 21, 2026 · Reincarn Science Team
Share
By Reincarn Science Team · September 2026 · 8 min read
Glycine for Sleep: What It Does, the Right Dose, and How It Compares to Melatonin
Glycine is an amino acid that improves sleep quality at a dose of 3,000 mg taken 30 to 60 minutes before bed. It works by triggering a drop in core body temperature through NMDA receptors in the brain's internal clock, which makes it distinctly different from melatonin. It does not cause insomnia. Three independent human trials support its use.
If you have searched for a sleep ingredient that works without sedation, without hormonal signalling, and without the habituation concerns that come with melatonin, glycine is worth understanding properly. This is not a supplement overview article. It is a mechanism-first explanation of what the evidence actually shows, including the dose, the pathway, and where it fits alongside or instead of other options.
What is glycine?
Glycine is the simplest amino acid. Your body produces it endogenously, and you consume it whenever you eat collagen-rich foods such as bone broth, skin-on poultry, or gelatin. It is classified as non-essential because the body can synthesise it, but research suggests endogenous production may not fully meet demand under some conditions.
As a neurotransmitter, glycine plays two distinct roles: it is inhibitory in the spinal cord and brainstem (via glycine receptors), and it is an obligatory co-agonist at NMDA receptors throughout the brain. The sleep effects come from this second pathway, in a specific brain region called the suprachiasmatic nucleus.
How glycine works for sleep
The mechanism was established in a 2015 animal study by Kawai and colleagues at Nagoya University, later supported by the human clinical data. When glycine is taken orally before bed, it reaches NMDA receptors in the shell of the suprachiasmatic nucleus (SCN), the brain's master clock. Activation of these receptors triggers peripheral vasodilation at the plantar surface of the feet and hands, which increases heat dissipation from the body. Core body temperature drops. That temperature drop signals sleep onset.
Key finding from Kawai et al. (2015): When the SCN was surgically ablated in the animal model, both the hypothermic and sleep-promoting effects of glycine were completely abolished. This confirms the SCN as the essential site of action, not a peripheral or non-specific effect.
The same study found that glycine did not alter plasma melatonin levels or the expression of core clock genes (Bmal1, Per2). This is important: glycine promotes sleep through thermoregulation, not through the circadian signalling pathway that melatonin uses. The two mechanisms are parallel, not overlapping.
What the human trials show
Three human studies are the primary evidence base.
Yamadera et al. (2007) gave 3 g of glycine or placebo to 11 adults with sleep complaints. Polysomnography showed shortened sleep latency, increased early-night slow-wave sleep, reduced REM latency, and improved subjective sleep quality scores. This is the anchor study for the 3,000 mg dose.
Bannai et al. (2012) studied 15 healthy volunteers under deliberate sleep restriction (25% less than habitual). Those given 3 g glycine before bed showed significantly reduced daytime sleepiness the next morning (Karolinska Sleepiness Scale), improved fatigue ratings, and improved psychomotor vigilance. Polysomnography confirmed shorter slow-wave sleep latency and more stable sleep architecture. The study was published in Frontiers in Neurology.
Inagawa et al. (2012) reviewed the consolidated evidence in the Journal of Pharmacological Sciences, confirming that 3 g glycine reduces time awake after sleep onset, shortens sleep onset time, and improves subjective rest quality.
All three studies used 3,000 mg. No dose-ranging trial comparing 1 g, 3 g, and 5 g in humans has been published. The 3 g figure is the consensus clinical dose because it is the only dose with controlled human evidence.
Glycine vs melatonin: two different pathways
These are not competing products trying to do the same thing. They act on different systems entirely.
| Feature | Melatonin | Glycine |
|---|---|---|
| Primary receptors | MT1/MT2 receptors in the SCN | NMDA receptors in the SCN shell |
| Primary action | Circadian phase signalling; shifts or stabilises the sleep-wake clock | Peripheral vasodilation, core temperature reduction |
| Affects circadian genes? | Yes (Bmal1, Per2 and others) | No effect on clock gene expression |
| Alters melatonin levels? | N/A | No, does not change melatonin production |
| Best suited for | Jet lag, shift work, circadian misalignment, delayed sleep phase | Sleep onset and quality issues with normal circadian timing; temperature-related poor sleep |
| Habituation risk | Some evidence of receptor downregulation at pharmacological doses | No evidence of habituation; endogenous substrate |
Melatonin makes sense when your internal clock is in the wrong phase. Glycine makes sense when your clock is fine but your body is not making the thermal shift into sleep quickly enough. Many people who say "melatonin doesn't work for me" are not circadian-misaligned; their sleep problem is thermoregulatory. That is a different target.
Glycine vs L-theanine for sleep
L-theanine and glycine are often compared because both are amino acids that appear in sleep formulas. But they act on different aspects of the problem.
| Feature | L-Theanine | Glycine |
|---|---|---|
| Primary mechanism | Increases alpha brain waves; modulates GABA and serotonin; reduces stress-induced arousal | NMDA activation in SCN, peripheral vasodilation, core temp reduction |
| Sleep pathway | Reduces pre-sleep anxiety and psychophysiological arousal | Physiological thermoregulation at sleep onset |
| EEG signature | Alpha wave induction at 50 to 250 mg (associated with relaxed, non-drowsy calm) | No alpha-wave data; acts on peripheral thermal pathway |
| Best for | Stress-driven poor sleep; trouble unwinding; racing thoughts at bedtime | Difficulty crossing into sleep even when relaxed; temperature-sensitive poor sleep |
| Synergy? | Yes, likely complementary: theanine addresses mental arousal, glycine addresses physiological readiness | |
If you cannot fall asleep because your mind is busy, L-theanine addresses that. If you lie in bed relaxed but cannot cross the threshold into sleep, glycine is more directly relevant. A formula containing both targets both barriers.
Can glycine cause insomnia?
No published trial has reported insomnia as an adverse effect of glycine at the 3,000 mg dose. The evidence runs in the opposite direction: glycine consistently shortens sleep latency and improves sleep quality. As an amino acid that is also produced endogenously and consumed through diet, glycine has a well-characterised safety profile. There is no biologically plausible mechanism by which a thermoregulatory temperature drop at sleep onset would worsen insomnia.
If you have seen suggestions online that glycine can disrupt sleep, these appear to be confusions with the stimulatory role of glycine as an NMDA co-agonist at high doses in non-sleep contexts, or anecdotal reports that may reflect other variables. The clinical data does not support this concern at sleep-relevant doses.
Glycine dosage for sleep
The studied dose is 3,000 mg (3 g), taken 30 to 60 minutes before bed. This is the dose used in every human trial cited in this article. There is no evidence that higher doses produce better sleep outcomes, and no dose-ranging trial has been conducted to establish a dose-response curve in humans.
Glycine is water-soluble and tasteless. It dissolves easily in water and is generally well tolerated. No significant adverse events were reported in any of the three primary trials.
REINCARN Night Reboot™ is formulated with Glycine at the 3,000 mg clinical dose alongside six other ingredients targeting different pathways in the sleep cycle. It is melatonin-free.
Join the WaitlistFrequently asked questions
How much glycine should I take for sleep?
The dose studied in clinical trials is 3,000 mg (3 g), taken 30 to 60 minutes before bed. This is the only dose with controlled human trial evidence for sleep outcomes.
Is glycine better than melatonin for sleep?
They target different problems. Melatonin is a circadian signal that helps shift or stabilise your sleep-wake clock. Glycine works through thermoregulation, lowering core body temperature to trigger sleep onset. If your circadian timing is normal but you still struggle to fall or stay asleep, glycine may be more directly relevant. They can also be used together as they operate on independent pathways.
Can glycine cause insomnia?
No. Clinical trials consistently show the opposite: glycine shortens sleep latency and improves sleep quality. No trial has reported insomnia as an adverse effect at the 3,000 mg sleep dose.
How does glycine work for sleep?
Glycine activates NMDA receptors in the suprachiasmatic nucleus (the brain's internal clock). This triggers peripheral vasodilation at the hands and feet, which increases heat dissipation from the body. Core body temperature drops, signalling sleep onset. It does not affect melatonin production or circadian clock genes.
What is the difference between glycine and L-theanine for sleep?
L-theanine reduces pre-sleep mental arousal, increases alpha brain waves, and helps with stress-driven inability to unwind. Glycine works physiologically to lower core body temperature. L-theanine is better for a busy, anxious mind at bedtime. Glycine is better for the physical act of crossing into sleep. The two mechanisms are complementary.
References
- Yamadera W, et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126-131.
- Bannai M, et al. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Frontiers in Neurology. 2012;3:61. PMC3328957
- Inagawa K, et al. Subjective effects of glycine ingestion before the sleep period on sleep quality. Journal of Pharmacological Sciences. 2012;118(2):145-148. PMID 22293292
- Kawai N, et al. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2015;40(6):1405-1416. PMC4397399
- Williams JL, et al. L-theanine effects on stress responses in high-stress individuals. Nutrients. 2021;13(7):2155. PMC8475422
Disclosure: Zandra Life Sciences makes REINCARN Night Reboot™, which contains Glycine at the 3,000 mg dose referenced in this article. This article is an independent evidence review.
Safety, interactions and honest limits
This is general educational information, not medical advice, and not a diagnosis or treatment for any condition. Reincarn Night Reboot is a food supplement to support sleep in healthy adults aged 18 and over, it is not a medicine and is not intended to diagnose, treat, cure or prevent any disease.
Who should check with a doctor first
Please speak to a doctor or pharmacist before use if you are pregnant or breastfeeding, under 18, taking any prescription medication (including sedatives, blood-pressure, thyroid, antidepressant or diabetes medicines), or living with a kidney, liver, heart or other ongoing medical condition. Because it contains magnesium, people with reduced kidney function should be especially careful, as magnesium can build up when the kidneys cannot clear it. Stop and seek advice if you have any unexpected reaction.
Other causes of poor sleep worth ruling out
Persistent poor sleep is not always about recovery or stress. It can be a sign of obstructive sleep apnoea, restless legs syndrome, anxiety or depression, chronic pain, thyroid problems, or a side effect of medication, and these need different care. If your sleep problems are ongoing, loud snoring or daytime sleepiness are involved, or nothing helps, see a doctor. For insomnia specifically, the recognised first-line treatment is cognitive behavioural therapy for insomnia (CBT-I) alongside good sleep habits, not a supplement.
What the evidence does and does not show
The research we cite is strongest for the individual ingredients at their studied doses. Reincarn Night Reboot has not yet been tested as a complete formulation in its own clinical trial, so evidence for a single ingredient should not be read as proof that the finished product works, or that it is better than alternatives. We share this openly, and a formulation study is on our roadmap.